Optimization, characterization and in vitro/vivo evaluation of azilsartan nanocrystals
Sign Up to like & getrecommendations! Published in 2017 at "Asian Journal of Pharmaceutical Sciences"
DOI: 10.1016/j.ajps.2016.09.008
Abstract: Graphical Abstract Through formulation screening, the irregular-shaped azilsartan nanocrystals were prepared and optimized by bead milling method and solidified by freeze-drying. The best formulation which had the size of 300 nm was expressed in its state… read more here.
Keywords: vitro vivo; azilsartan nanocrystals; azilsartan; characterization vitro ... See more keywords
A0869 Antihypertensive effect and safety of Azilsartan compared with other Angiotensin Receptor Blockers: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000548442.52495.5d
Abstract: Objectives: Azilsartan medoxomil, angiotensin II type I receptor antagonists (ARB), as the eight ARB was permitted by United States Food and Drug Administration (FDA) in 2011 for treatment of hypertension contribution to it perfect efficiency… read more here.
Keywords: safety; blood pressure; azilsartan; effect ... See more keywords
Practical efficacy of olmesartan versus azilsartan in patients with hypertension: a multicenter randomized-controlled trial (MUSCAT-4 study)
Sign Up to like & getrecommendations! Published in 2017 at "Blood Pressure Monitoring"
DOI: 10.1097/mbp.0000000000000229
Abstract: Background Olmesartan and azilsartan, angiotensin II receptor blockers (ARBs), are expected to decrease blood pressure more than the other ARBs. We conducted randomized-controlled trials to compare the practical efficacy of olmesartan with azilsartan. Methods Eighty-four… read more here.
Keywords: practical efficacy; olmesartan azilsartan; group; blood pressure ... See more keywords